A study found Barrett's esophagus patients taking proton-pump inhibitors and either a nonsteroidal anti-inflammatory drug or a statin reduced their risk of esophageal adenocarcinoma. Data showed those who filled prescriptions for NSAID/aspirin were 36% less likely to have esophageal cancer and those who filled statin prescriptions had a 45% reduced risk.

Related Summaries